Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.44 |
| ▸ | CA2 | P00918 | 5/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17061022 | 0.92 | CA1 (0.52) | CA1CA2CA12CA7CA9 | |
| Selenic Acid SCHEMBL29153994 | 0.88 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| Butane SCHEMBL976220 | 0.82 | LTA4H (0.38) | — | |
| Butane SCHEMBL11055059 | 0.80 | CA1 (0.55) | CA1CA2CA12CA7CA9 | |
| SCHEMBL15849787 | 0.80 | MEN1 (0.30) | — | |
| Butane SCHEMBL4325616 | 0.79 | SMN1; SMN2 (0.46) | CA1CA2CA9HDAC3HDAC1 | |
| Butane SCHEMBL3765407 | 0.78 | IDO1 (0.47) | HTTLDHA | |
| Butane SCHEMBL8387084 | 0.78 | CHRNB2 (0.41) | TAS1R3TAS1R1GSK3BHDAC8 | |
| Butane SCHEMBL9159352 | 0.78 | MGLL (0.47) | CA1CA2CA9PARP10PARP2 | |
| SCHEMBL17061036 | 0.78 | NQO1 (0.58) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3674347-B1 | ETHYLENEIMINE POLYMER SOLUTION | NIPPON CATALYTIC CHEM IND (JP) | 2023-12-20 | — | — | EP | disclosed |
| US-11332616-B2 | Ethyleneimine polymer solution and method for producing same | NIPPON SHOKUBAI CO., LTD. (JP) | 2022-05-17 | — | — | US | disclosed |
| US-20200362168-A1 | ETHYLENEIMINE POLYMER SOLUTION AND METHOD FOR PRODUCING SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 2020-11-19 | — | — | US | disclosed |
| EP-3674347-A1 | ETHYLENEIMINE POLYMER SOLUTION AND METHOD FOR PRODUCING SAME | Nippon Shokubai Co., Ltd. (JP) | 2020-07-01 | — | — | EP | disclosed |
| EP-2492258-A1 | METHOD FOR MANUFACTURING A TRICYCLODECANE MONO-METHANOL MONOCARBOXYLIC ACID DERIVATIVE | Hitachi Chemical Company, Ltd. (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20120203026-A1 | METHOD FOR MANUFACTURING TRICYCLODECANE MONO-METHANOL MONOCARBOXYLIC ACID DERIVATIVE | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2012-08-09 | — | — | US | disclosed |
| US-8062816-B2 | Phosphonate hole blocking layer photoconductors | XEROX CORPORATION (US) | 2011-11-22 | — | — | US | disclosed |
| US-20090297967-A1 | PHOSPHONATE HOLE BLOCKING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-12-03 | — | — | US | disclosed |
| EP-2128709-A1 | Phosphonate Hole Blocking Layer Photoconductors | Xerox Corporation (US) | 2009-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120203026-A1 | METHOD FOR MANUFACTURING TRICYCLODECANE MONO-METHANOL MONOCARBOXYLIC ACID DERIVATIVE | MCCC2, HACL2, HPD | CA1 45/4885CA2 61/4885CA12 62/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.